Assenagon Asset Management »

Fate Therapeutics shares owned by Assenagon Asset Management

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Assenagon Asset Management from 13F filings

Historical chart of Assenagon Asset Management investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Assenagon Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.5M 2.4M 3.50
2024-06-30 $8.4M 2.6M 3.28
2024-03-31 $19M 2.5M 7.34
2023-12-31 $610k 163k 3.74
2023-09-30 $807k 381k 2.12
2023-06-30 $475k 100k 4.76
2022-09-30 $327k 15k 22.42
2022-06-30 $362k 15k 24.79
2022-03-31 $566k 15k 38.74
2021-12-31 $855k 15k 58.50
2021-09-30 $7.4M 125k 59.27
2021-06-30 $36M 417k 86.79
2020-12-31 $2.3M 25k 90.95
2020-09-30 $3.3M 83k 39.96
2020-06-30 $1.4M 40k 34.30